Determination of the time-dependent association between ciprofloxacin consumption and ciprofloxacin resistance using a weighted cumulative exposure model compared with standard models.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
van Gaalen, Rolina DAltorf-van der Kuil, Wieke
Wegdam-Blans, Marjolijn C A
Aguilar Diaz, Jessica M
Beauchamp, Marie-Eve
Chaname Pinedo, Linda E
de Greeff, Sabine C
Wallinga, Jacco
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Determination of the time-dependent association between ciprofloxacin consumption and ciprofloxacin resistance using a weighted cumulative exposure model compared with standard models.Published in
J Antimicrob Chemother 2020; 75:8:226-33PMID
32407492ae974a485f413a2113503eed53cd6c53
10.1093/jac/dkaa141
Scopus Count
Collections
Related articles
- Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
- Authors: Mulder M, Kiefte-de Jong JC, Goessens WH, de Visser H, Hofman A, Stricker BH, Verbon A
- Issue date: 2017 Jan
- A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.
- Authors: Fox MT, Melia MT, Same RG, Conley AT, Tamma PD
- Issue date: 2017 Jul
- Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study.
- Authors: Cienfuegos-Gallet AV, Ocampo de Los Ríos AM, Sierra Viana P, Ramirez Brinez F, Restrepo Castro C, Roncancio Villamil G, Del Corral Londoño H, Jiménez JN
- Issue date: 2019 Oct 7
- Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
- Authors: Ten Doesschate T, van Mens SP, van Nieuwkoop C, Geerlings SE, Hoepelman AIM, Bonten MJM
- Issue date: 2018 Dec 5
- Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime.
- Authors: Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr T, Andersen MH, Løken J, Tousi H, Søe-Jensen P, Lauritsen AØ, Strange D, Petersen JA, Thormar K, Larsen KM, Drenck NE, Helweg-Larsen J, Johansen ME, Reinholdt K, Møller JK, Olesen B, Arendrup MC, Østergaard C, Cozzi-Lepri A, Grarup J, Lundgren JD, Procalcitonin and Survival Study Group
- Issue date: 2015 Mar